The field of extracellular vesicle (EV) research has developed rapidly over the last decade from the study of fundamental biology to a subject of significant clinical relevance. The potential of harnessing EVs in the diagnosis and treatment of diseases — including cancer and neurological and cardiovascular disorders — is now being recognized. Accordingly, the applications of EVs as therapeutic targets, biomarkers, novel drug delivery agents and standalone therapeutics are being actively explored. This Review provides a brief overview of the characteristics and physiological functions of the various classes of EV, focusing on their association with disease and emerging strategies for their therapeutic exploitation.<p></p>
Funding
Research in the Hill lab is supported by grants from the National Health and Medical Research Council of Australia (to A.F.H. GNT1041413; GNT1132604), and the Australian Research Council (to A.F.H. DP170102312; DP190101655).